Overview

Treatment of Tinnitus With Migraine Medications

Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
Tinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. It is well-understood that many factors, such as poor education, lower income, or occupational, and recreational activity associated with high noise exposure, influences the prevalence and risk of tinnitus. Although the economic and emotional impact of tinnitus is large, there is currently no FDA-approved medication to treat this condition. However, there are pharmacological options to address the stress, anxiety, and depression that are caused by tinnitus. In this project, we intend to use medications for patients with tinnitus in order to decrease the impact of tinnitus on their daily life and activities.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, Irvine
Treatments:
Nortriptyline
Paroxetine
Topiramate
Verapamil